Gendicine in terminal cancer

[Guest guest]

Hi KAL, Pete & All,

 

> >

http://health.telegraph.co.uk/news/main.jhtml?xml=/news/2004/07/04/wgene04.xml

 

See also: See: http://www.nbsc.compapers/BP5-08-04Ae.pdf

 

In clinical trials, Gendicine has been used to successfully treat cancers

of the digestive tract (esophageal, gastric, intestine, liver, pancreas,

gallbladder, rectum), lung cancer, sarcoma, thyroid- gland cancer,

breast cancer, cervical cancer, and ovarian cancer. Although Gendicine

has not been formally approved by SFDA for indications other than

HNSCC, terminal patients with no other avenue of treatment have been

allowed, on a case-by-case basis, to receive Gendicine with permission

from the SFDA, along with a request from the patient, the patient’s

family, and the agreement of the patient’s doctor. We also insist that the

patient, family, and the doctor-in-charge carefully read and endorse the

informed consent forms

 

Is this another hype, or are the Chinese really on to something great

here?

 

Best regards,

 

Email: <

 

WORK : Teagasc, c/o 1 Esker Lawns, Lucan, Dublin, Ireland

Mobile: 353-; [in the Republic: 0]

 

HOME : 1 Esker Lawns, Lucan, Dublin, Ireland

Tel : 353-; [in the Republic: 0]

WWW : http://homepage.eircom.net/~progers/searchap.htm

 

Chinese Proverb: " Man who says it can't be done, should not interrupt

man doing it "